{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:53:52Z","timestamp":1761519232170,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.4158\/ep-2017-0261","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T12:43:42Z","timestamp":1530794622000},"page":"805-814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Predictors and Clinical Outcomes of Treatment Intensification in Patients with Type 2 Diabetes Uncontrolled on Basal Insulin in a Real-World Setting"],"prefix":"10.1016","volume":"24","author":[{"given":"Lee","family":"Kallenbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy M.","family":"Shui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy Y.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenli","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam L.","family":"Zichlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei Sheng","family":"Duh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip A.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2017-0261_bb0010","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2017-0261_bb0015","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2017-0261_bb0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/dom.13088","article-title":"Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: a systematic review","volume":"20","author":"Khunti","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"suppl 3","key":"10.4158\/EP-2017-0261_bb0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1185\/03007995.2011.621416","article-title":"Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes","volume":"27","author":"Ross","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.4158\/EP-2017-0261_bb0030","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/dom.12977","article-title":"Future challenges and therapeutic opportunities in type 2 diabetes: changing the pardigm of current therapy","volume":"19","author":"Owens","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"9 Suppl 1","key":"10.4158\/EP-2017-0261_bb0035","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.amjmed.2013.06.012","article-title":"Breaking down patient and physician barriers to optimize glycemic control in type 2 diabetes","volume":"126","author":"Ross","year":"2013","journal-title":"Am J Med"},{"key":"10.4158\/EP-2017-0261_bb0040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/1753-0407.12410","article-title":"Clinical inertia causing new or progression of diabetic retinopathy in type 2 diabetes: a retrospective cohort study","volume":"9","author":"Osataphan","year":"2017","journal-title":"J Diabetes"},{"key":"10.4158\/EP-2017-0261_bb0045","first-page":"503","article-title":"Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus","volume":"12","author":"Christensen","year":"2009","journal-title":"IDrugs"},{"key":"10.4158\/EP-2017-0261_bb0050","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2146\/ajhp140168","article-title":"Dapagliflozin: a new sodium-glucose cotransporter 2 inhibitor for treatment of type 2 diabetes","volume":"72","author":"Vivian","year":"2015","journal-title":"Am J Health Syst Pharm"},{"key":"10.4158\/EP-2017-0261_bb0055","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrendo.2016.86","article-title":"Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus","volume":"12","author":"Tahrani","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.4158\/EP-2017-0261_bb0060","unstructured":"Centers for Disease Control and PreventionAbout Adult BMI. Available at: http:\/\/www.cdc.gov\/healthyweight\/assessing\/bmi\/adult_bmi\/index.html. Accessed July 11, 2018."},{"key":"10.4158\/EP-2017-0261_bb0065","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2337\/dc12-2480","article-title":"Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society","volume":"36","author":"Seaquist","year":"2013","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2017-0261_bb0070","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2337\/cd17-0064","volume":"36","author":"Wysham","year":"2018","journal-title":"Clin Diabetes"},{"key":"10.4158\/EP-2017-0261_bb0075","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/ijcp.12906","article-title":"Under-treatment of type 2 diabetes: causes and outcomes of clinical inertia","volume":"70","author":"Bailey","year":"2016","journal-title":"Int J Clin Pract"},{"key":"10.4158\/EP-2017-0261_bb0080","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4158\/EP15868.OR","article-title":"Does clinical inertia vary by personalized A1C goal? A study of predictors and prevalence of clinical inertia in a U.S. managed-care setting","volume":"22","author":"Lin","year":"2016","journal-title":"Endocr Pract"},{"key":"10.4158\/EP-2017-0261_bb0085","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/dom.12626","article-title":"Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin","volume":"18","author":"Khunti","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.4158\/EP-2017-0261_bb0090","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.pcd.2017.05.008","article-title":"Factors associated with prolonged inaction in the hypoglycaemic treatment in people with non-insulin dependent type 2 diabetes and elevated glycated haemoglobin: a registry-based cohort study","volume":"11","author":"Goderis","year":"2017","journal-title":"Prim Care Diabetes"},{"key":"10.4158\/EP-2017-0261_bb0095","first-page":"e418","article-title":"Clinical inertia in patients with T2D requiring insulin in family practice","volume":"56","author":"Harris","year":"2010","journal-title":"Can Fam Physician"},{"key":"10.4158\/EP-2017-0261_bb0100","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jdiacomp.2015.03.019","article-title":"Ascertainment of outpatient visits by patients with diabetes: the National Ambulatory Medical Care Survey (NAMCS) and the National Hospital Ambulatory Medical Care Survey (NHAMCS)","volume":"29","author":"Asao","year":"2015","journal-title":"J Diabetes Complications"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20353611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20353611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:05:17Z","timestamp":1761516317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20353611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1530891X20353611"],"URL":"https:\/\/doi.org\/10.4158\/ep-2017-0261","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors and Clinical Outcomes of Treatment Intensification in Patients with Type 2 Diabetes Uncontrolled on Basal Insulin in a Real-World Setting","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2017-0261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}